SUNY Downstate Health Sciences University

Running trials

• Recruiting

  Efficacy and Safety of a Botanical Total Coumarin (TC) Cream in Treating Patients With Psoriasis Vulgaris (PLANTCOAT-III)

  NCT07426120· Phase 3· Psoriasis Research Institute of Guangzhou· Source

• Recruiting

  A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo

  NCT06548360· Phase 3· Incyte Corporation· Source

• Active, not recruiting

  Beta Cell Function in Type 2 Diabetes: Differential Effects of SGLT2 Inhibitors and GLIP-Receptor Agonists

  NCT07325435· Phase 4· MaryAnn Banerji· Source

• Recruiting

  Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

  NCT05485961· Phase 2/3· CSL Behring· Source

• Recruiting

  Phase 2A Pilot C3 Trial of Recurrent/Refractory Metastatic Advanced Pancreatic Cancer

  NCT06030622· Phase 1/2· State University of New York - Downstate Medical Center· Source

• Active, not recruiting

  A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo

  NCT06163326· Phase 3· Pfizer· Source

• Enrolling by invitation

  Safety Study of Tenapanor for the Treatment of Pediatric Patients (6 to Less Than 18 Years Old) With IBS-C

  NCT05905926· Phase 3· Ardelyx· Source

• Active, not recruiting

  Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis

  NCT05047172· Phase 3· University of Florida· Source

• Active, not recruiting

  A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease

  NCT05197049· Phase 3· Janssen Research & Development, LLC· Source

• Active, not recruiting

  14022 ATTUNE Cementless RP Clinical Performance Evaluation

  NCT02839850· DePuy Orthopaedics· Source

• Active, not recruiting

  Risk Factors for Endometrial Cancer in Black Women

  NCT00514254· Memorial Sloan Kettering Cancer Center· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Chronic kidney disease1 recruiting
• Coronary artery disease1 recruiting
• Irritable bowel syndrome1 recruiting
• Pancreatic cancer1 recruiting
• Peripheral artery disease1 recruiting
• Psoriasis1 recruiting
• Vitiligo1 recruiting

Closed trials

• Completed

  4-Week, Multi-center Dose-Ranging Study for the IBS-C in Pts. 6 to <12 Yrs

  NCT06553547· Phase 2· Ardelyx· Source

• Completed

  Efficacy and Safety of Lorundrostat in Addition to Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) in Subjects With Hypertension and Chronic Kidney Disease (CKD) With Albuminuria

  NCT06150924· Phase 2· Mineralys Therapeutics Inc.· Source

• Completed

  A Study to Learn More About the Safety and Effects of Felzartamab in Adults With Lupus Nephritis Aged 18 to 75 Years Old

  NCT06064929· Phase 1· HI-Bio, A Biogen Company· Source

• Completed

  Assessing Perceptions and Preferences Around Long-acting Injectables (APPLI)

  NCT05833542· City University of New York· Source

• Completed

  A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk

  NCT05803421· Phase 3· Eli Lilly and Company· Source

• Terminated

  The Purpose of This Study is to Evaluate the Effects of Ruxolitinib Cream on Adults With Atopic Dermatitis Experiencing Sleep Disturbance.

  NCT05696392· Phase 4· Incyte Corporation· Source

• Withdrawn

  Pimavanserin for Sleep in Parkinson Disease

  NCT05796167· Early phase 1· State University of New York - Downstate Medical Center· Source

• Completed

  A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke

  NCT05686070· Phase 3· Bayer· Source

• Completed

  Dupilumab in Adolescent and Adult Skin of Color Participants: Open-label Moderate-to-severe Eczema Trial

  NCT05590585· Phase 4· Regeneron Pharmaceuticals· Source

• Completed

  A 52-Week Study of Ritlecitinib Oral Capsules in Adults and Adolescents With Nonsegmental Vitiligo (Active and Stable) Tranquillo

  NCT05583526· Phase 3· Pfizer· Source

• Completed

  Study to Assess Safety and Efficacy of Tenapanor for Treatment of IBS-C in Pediatric Patients 12 to Less Than 18 Years

  NCT05643534· Phase 3· Ardelyx· Source

• Completed

  Light Treatment Effectiveness (LITE) Study

  NCT03726489· University of Pennsylvania· Source

• Completed

  EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin)

  NCT03594110· Phase 3· Boehringer Ingelheim· Source

• Completed

  A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated Pain

  NCT03213457· Phase 3· AbbVie· Source

• Completed

  Everolimus and Letrozole or Hormonal Therapy to Treat Endometrial Cancer

  NCT02228681· Phase 2· GOG Foundation· Source

• Terminated

  Combination of Serum Measurements of Molecular Biomarkers and Serum Protein Profiling Can be Used to Predict Which Patients Undergoing Prostatic Biopsy Will be Diagnosed With Cancer

  NCT00773773· Memorial Sloan Kettering Cancer Center· Source

• Completed

  Surveillance Monitoring for ART Toxicities Study in HIV Uninfected Children Born to HIV Infected Women

  NCT01310023· Harvard School of Public Health (HSPH)· Source

• Completed

  Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer

  NCT00309985· Phase 3· ECOG-ACRIN Cancer Research Group· Source

Conditions

Diseases this institution publishes on or runs trials for.

• HIV104 works · 2 trials
• Lupus (SLE)18 works · 1 trial
• Familial hypercholesterolaemia4 works · 0 trials